Is a complete LON/GENF research report available?

No complete published report is available for lon/GENF (LON/GENF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/GENF (LON/GENF)

London Stock Exchange: LON/GENF · GBX

GBX 2.40

-0.06 (-2.4%)· Recorded snapshot

Market cap	13.6M
Revenue (ttm)	585.6K
Net income (ttm)	-1.4M
EPS (ttm)	-GBX 0.00
Shares out	566.4M
Volume	0
Beta	2.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 585.6K
Net income (ttm): -1.4M
EPS (ttm): -GBX 0.00
Market cap: 13.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-09 02:00 UTC

All LON/GENF indicators

Market & fundamental data

Available fields

157

Groups with data

Currency

GBP

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	5
Employees Change	0%
Employees Change Percent	0
Enterprise value	GBX 13.5M
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BP2C3V08
Last refreshed	2026-09-09
Market cap	GBX 13.6M
Price	GBX 2.4
Price currency	GBX
Rev Per Employee	117,121.4x
Sector	Healthcare
Sector PE	21.51
Sector PE Fwd	13.73
Sic	2836
Symbol	lon/GENF
Website	https://genflowbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.43%
EV/Sales	23.02x
FCF yield	-10.57%
P/B ratio	-24.68x
P/S ratio	23.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-242.07%
EBITDA Margin	-241.88%
Gross margin	100%
Gross Profit	GBX 585,607
Gross Profit Growth	82.73%
Gross Profit Growth Q	82.73%
Net Income	GBX -1.4M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	-242.07%
Profit Margin	-242.07%
Profit Per Employee	GBX -283,513
ROA	-211.4
ROCE	257.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	182.55%
Cagr3y	-1.35%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth	82.73x
Revenue Growth Q	82.73x
Revenue Growth Quarters	4x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 1.4
Assets	GBX 452,386
Cash	GBX 111,792
Current Assets	GBX 451,320
Current Liabilities	GBX 1M
Debt	GBX 0
Equity	GBX -550,785
Liabilities	GBX 1M
Long Term Assets	GBX 1,066
Long Term Liabilities	GBX 0
Net Cash	GBX 111,792
Net Cash By Market Cap	GBX 0.82
Net Cash Growth	-59.89%
Tangible Book Value	GBX -550,785
Tangible Book Value Per Share	GBX -0
WACC	16.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.45
Net Working Capital	GBX -663,643
Quick ratio	0.41
Working Capital	GBX -551,851
Working Capital Turnover	GBX -1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	182.35%
200-day SMA	2.01
3Y total return	-4%
50-day SMA	1.99
50-day SMA vs 200-day SMA	50under200
All Time High	13.5
All Time High Change	-82.22%
All Time High Date	2022-02-02
All Time Low	0.55
All Time Low Change	336.36%
All Time Low Date	2025-07-17
ATR	0.2
Beta	2.28
Beta1y	-1.97
Beta2y	-0.73
Ch YTD	29.73
High	2.94
High52	3.12
High52 Date	2026-04-30
High52ch	-23.08%
Low	2.4
Low52	0.8
Low52 Date	2025-09-15
Low52ch	200%
Ma50ch	20.72%
Price vs 200-day SMA	19.23%
RSI	68.15
RSI Monthly	51.02
RSI Weekly	59.24
Sharpe ratio	1.28x
Sharpe Ratio3y	0.38x
Sortino ratio	2.93
Sortino Ratio3y	0.79
Total Return	-27.58%
Tr YTD	29.73
Tr1m	17.07%
Tr1w	17.07%
Tr3m	12.94%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	325,387,109%
Shares Insiders	41.26%
Shares Institutions	43.06%
Shares Out	566,409,782
Shares Qo Q	22.08%
Shares Yo Y	27.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,630,404.25x
Bv Per Share	-0
Ch1m	17.07
Ch1w	17.07
Ch1y	182.4
Ch3m	12.94
Ch3y	-4
Ch6m	29.73
Change	-2.44%
Change From Open	-16.67
Close	2.46
Days Gap	17.07
Depreciation Amortization	1,093
Earnings Date	2026-09-28
EBIT	GBX -1.4M
EBITDA	GBX -1.4M
EPS	GBX -0
F Score	1
FCF	GBX -1.4M
FCF EV Yield	-10.66x
FCF Per Share	GBX -0
Financing CF	1,308,698
Fiscal Year End	December
Founded	2,020
Is Primary Listing	1
Last Earnings Date	2025-12-30
Last Report Date	2025-12-31
Ma150	2.07
Ma150ch	16.22%
Ma20	2.07
Ma20ch	16.11%
Net CF	-166,890
Next Earnings Date	2026-09-28
Open	2.88
Position In Range	0
Ppne	1,066
Price Date	2026-09-08
Relative Volume	10.57x
Revenue	585,607x
Tr6m	29.73%
Volume	0
Z Score	-28.71

LON/GENF (LON/GENF)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/GENF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/GENF indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/GENF

Frequently asked questions